Schedule 13G ownership disclosure

DA32 Life Science Tech Acquisition Corp.

Security class unavailable · CUSIP: 23312M106

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,479,148
Percent of class
5.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001678858-22-000001
Form type
SC 13G
Filer
DA32 Life Science Tech Acquisition Corp.
CIK
CIK 1863294
Filed
Feb 04, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub